Literature DB >> 1652447

Evidence for two high-affinity bradykinin binding sites in the guinea-pig lung.

A Trifilieff1, E B Haddad, Y Landry, J P Gies.   

Abstract

We examined the binding of [3H]bradykinin ([3H]BK) to the guinea-pig lung which was saturable. Scatchard analysis indicated the existence of two binding sites, one with a high affinity (KD = 15 pM) and one with a low one (KD = 570 pM) with maximum number of binding sites of 12 and 45 fmol/mg protein, respectively. Kinetic studies confirmed the presence of these two types of binding sites and their affinity ranges. Neither the B1 agonist des-Arg9-BK, nor the B1 antagonist des-Arg9-[Leu8]BK displaced [3H]BK, demonstrating the absence of B1 receptors in the guinea-pig lung. Current B2 antagonists fully displaced the [3H]BK binding. Their potencies differed slightly according to the concentration of [3H]BK, suggesting a specificity of current B2 antagonists for the lower affinity site as opposed to the higher one. Altogether, these results do not allow us to confirm the occurrence of putative B3 receptors in guinea-pig lung.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652447     DOI: 10.1016/0922-4106(91)90087-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140.

Authors:  J W Dear; K Wirth; G K Scadding; J C Foreman
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway.

Authors:  S Isami; H Kishikawa; E Araki; M Uehara; K Kaneko; T Shirotani; M Todaka; S Ura; S Motoyoshi; K Matsumoto; N Miyamura; M Shichiri
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

3.  Pharmacological and functional characterization of bradykinin receptors in canine cultured tracheal epithelial cells.

Authors:  S F Luo; C T Tsai; W B Wu; S L Pan; Y J Tsai; C M Yang
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Bradykinin binding sites in healthy and carcinomatous human lung.

Authors:  A Trifilieff; E Lach; P Dumont; J P Gies
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  Pharmacological evidence for a single bradykinin B2 receptor in the guinea-pig.

Authors:  D Pruneau; J M Luccarini; E Defrêne; J L Paquet; P Bélichard
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

6.  Bradykinin-induced contraction of guinea pig lung in vitro.

Authors:  E Lach; A Trifilieff; M Mousli; Y Landry; J P Gies
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

7.  Pharmacological characterization of bradykinin receptors in canine cultured tracheal smooth muscle cells.

Authors:  C M Yang; S F Luo; H C Hsia
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Bradykinin-stimulated phosphoinositide metabolism in cultured canine tracheal smooth muscle cells.

Authors:  C M Yang; H C Hsia; S P Chou; R Ong; J T Hsieh; S F Luo
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.